Histopathology: Tumor Type, Grade, and Surgical Margins

Histopathology examines fixed tissue architecture and usually provides more specific tumor classification than cytology. Depending on tumor type and specimen, the report may include grade, mitotic activity, invasion, margins, and other features that inform local and systemic planning.

A biopsy or surgical specimen is preserved, processed into thin sections, stained, and interpreted by a pathologist. Immunohistochemistry, special stains, molecular testing, or external review may be added when routine appearance does not fully resolve the diagnosis.

It converts a suspected tumor into a tissue diagnosis and helps determine whether the first surgery was complete, whether re-excision or radiation should be discussed, and whether grade-specific staging or systemic treatment is relevant.

The most useful report requires a representative, properly handled specimen and clinical context. Surgeon orientation, inked margins, labeled anatomic sites, and a clear history help the pathologist answer the treatment question.

Used after incisional, punch, core, endoscopic, or excisional biopsy and after organ or mass removal. It is especially important before relying on terms such as benign, malignant, low grade, or clean margins.

AAHA diagnostic guidance notes that histopathology commonly supplies specific histology, higher confidence in benign-versus-malignant classification, margin width, and grade when relevant, although some tumors still require additional testing or expert review.

Risk comes mainly from obtaining the tissue: anesthesia, bleeding, wound complications, sampling error, or an incision that compromises later surgery. Pathology itself does not eliminate biologic uncertainty or guarantee outcome.

A margin report applies to the submitted specimen and sampled sections, not every cell in the patient. Keep the complete report and request clarification of ambiguous wording rather than relying on a verbal “all clear.”